Radiant Biotherapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$35M
- Investors
-
10
Radiant Biotherapeutics General Information
Description
Developer of a modular, multi-valent, and multi-specific platform intended to create antibodies for the treatment of cancer, inflammation, and infections. The company's platform offers multi-functional biologics to tackle difficult-to-treat diseases such as cancer, autoimmune diseases, and infectious diseases, enabling healthcare professionals to exploit avidity and binding power coupled with multi-specificity to deliver potent multi-functional biologics with the potential to unlock cures for patients.
Contact Information
Website
www.radiantbio.comCorporate Office
- 686 Bay Street, PGCRL 21.9430.X
- Admin Room 21.9800 U1 E
- Toronto, Ontario M5G 0A4
- Canada
Corporate Office
- 686 Bay Street, PGCRL 21.9430.X
- Admin Room 21.9800 U1 E
- Toronto, Ontario M5G 0A4
- Canada
Radiant Biotherapeutics Timeline
Radiant Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC (Series A) | 27-Aug-2024 | $35M | Completed | Pre-Clinical Trials | ||
| 4. Seed Round | 25-Apr-2023 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 22-Dec-2020 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Sep-2020 | Completed | Startup | |||
| 1. University Spin-Out | 07-Aug-2020 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Radiant Biotherapeutics Comparisons
Industry
Financing
Details
Radiant Biotherapeutics Competitors (3)
One of Radiant Biotherapeutics’s 3 competitors is Numab Therapeutics, a Venture Capital-Backed company based in Horgen, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Numab Therapeutics | Venture Capital-Backed | Horgen, Switzerland | ||||
| Inhibrx | Formerly VC-backed | La Jolla, CA | ||||
| IGM Biosciences | Formerly VC-backed | Mountain View, CA |
Radiant Biotherapeutics Patents
Radiant Biotherapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023407259-A1 | Multivalent and multispecific cytokine antagonists | Pending | 18-Dec-2022 | ||
| EP-4634237-A1 | Multivalent and multispecific cytokine antagonists | Pending | 18-Dec-2022 | ||
| US-20260209339-A1 | Multivalent and multispecific cytokine antagonists | Pending | 18-Dec-2022 | ||
| WO-2024130394-A1 | Multivalent and multispecific cytokine antagonists | Inactive | 18-Dec-2022 | ||
| AU-2023407260-A1 | Multivalent hematopoietic cell engagers or activators | Pending | 18-Dec-2022 | A61K47/62 |
Radiant Biotherapeutics Signals
Radiant Biotherapeutics Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aberdeen Investments (Scotland) | Asset Manager | Minority | ||
| BDC Capital | Growth/Expansion | Minority | ||
| Gates Foundation | Not-For-Profit Venture Capital | Minority | ||
| Alexandria Venture Investments | Venture Capital | Minority | ||
| SickKids | Corporation | Minority |
Radiant Biotherapeutics FAQs
-
When was Radiant Biotherapeutics founded?
Radiant Biotherapeutics was founded in 2020.
-
Where is Radiant Biotherapeutics headquartered?
Radiant Biotherapeutics is headquartered in Toronto, Canada.
-
What is the size of Radiant Biotherapeutics?
Radiant Biotherapeutics has 14 total employees.
-
What industry is Radiant Biotherapeutics in?
Radiant Biotherapeutics’s primary industry is Drug Discovery.
-
Is Radiant Biotherapeutics a private or public company?
Radiant Biotherapeutics is a Private company.
-
What is Radiant Biotherapeutics’s current revenue?
The current revenue for Radiant Biotherapeutics is .
-
How much funding has Radiant Biotherapeutics raised over time?
Radiant Biotherapeutics has raised $43.1M.
-
Who are Radiant Biotherapeutics’s investors?
Aberdeen Investments (Scotland), BDC Capital, Gates Foundation, Alexandria Venture Investments, and SickKids are 5 of 10 investors who have invested in Radiant Biotherapeutics.
-
Who are Radiant Biotherapeutics’s competitors?
Numab Therapeutics, Inhibrx, and IGM Biosciences are competitors of Radiant Biotherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process